Share Twitter LinkedIn Facebook Email Ajai Chari, MD, Mt. Sinai , explains, Unmet Need for LenD Refractory Patients | No One Regimen that is Appropriate for All Patients at Annual Meeting 2018
53 vs 31 Month Isatuximab-VRD Results: My Interview with SANOFI’s Global Product Head at ASCO 2024 ASCO Annual Meeting 2 Mins Read